A detailed history of Wellington Management Group LLP transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 51,300 shares of AUPH stock, worth $787,455. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,300
Previous 55,217 7.09%
Holding current value
$787,455
Previous $467,000 21.2%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$7.47 - $13.14 $29,259 - $51,469
-3,917 Reduced 7.09%
51,300 $566,000
Q2 2025

Aug 14, 2025

BUY
$7.2 - $8.64 $194 - $233
27 Added 0.05%
55,217 $467,000
Q1 2025

May 13, 2025

BUY
$7.55 - $8.77 $416,684 - $484,016
55,190 New
55,190 $443,000
Q4 2024

Feb 12, 2025

BUY
$6.75 - $10.44 $410,069 - $634,240
60,751 New
60,751 $545,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $2.18B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.